Related references
Note: Only part of the references are listed.Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies
Robby Nieuwlaat et al.
CLINICAL INFECTIOUS DISEASES (2021)
Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience
Christopher J. Lehmann et al.
CLINICAL INFECTIOUS DISEASES (2021)
Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study
Valerie M. Vaughn et al.
CLINICAL INFECTIOUS DISEASES (2021)
Understanding the role of bacterial and fungal infection in COVID-19
Timothy M. Rawson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Transcriptional response modules characterize IL-1β and IL-6 activity in COVID-19
Lucy C. K. Bell et al.
ISCIENCE (2021)
Using the kinetics of C-reactive protein response to improve the differential diagnosis between acute bacterial and viral infections
Dan Coster et al.
INFECTION (2020)
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
Heshui Shi et al.
LANCET INFECTIOUS DISEASES (2020)
COVID-19 and the potential long-term impact on antimicrobial resistance
Timothy M. Rawson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Annemarie B. Docherty et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting
S. Hughes et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
Bradley J. Langford et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease
Simon E. Brill et al.
BMC MEDICINE (2020)
Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study
Dayle Sampson et al.
BMC MEDICINE (2020)
Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019
Lu-shan Xiao et al.
EBIOMEDICINE (2020)
Prognostic value of interleukin-6, C -reactive protein, patients with COVID-19 and procalcitonin in
Fang Liu et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis
Bilian Yu et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
Stephen R. Knight et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
Jessica J. Manson et al.
LANCET RHEUMATOLOGY (2020)
The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09
Chandini Raina MacIntyre et al.
BMC INFECTIOUS DISEASES (2018)
Time Efficiency Assessment of Antimicrobial Stewardship Strategies
Gabriele Pollara et al.
CLINICAL INFECTIOUS DISEASES (2017)
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
Evelien de Jong et al.
LANCET INFECTIOUS DISEASES (2016)
elCID: An electronic Clinical Infection Database to support integrated clinical services and research in infectious diseases
Michael Marks et al.
JOURNAL OF INFECTION (2015)
Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis
Roman Pfister et al.
CRITICAL CARE (2014)
Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis
Meng-Huan Wu et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study
Luis M. Coelho et al.
CRITICAL CARE (2012)
Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia
Shin Ahn et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2011)
Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study
E. Cuquemelle et al.
INTENSIVE CARE MEDICINE (2011)
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness
David M. Morens et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system
E García-Vázquez et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Share Paper
